UnaliWear has filed a second complaint with the US International Trade Commission, the federal agency that can bar products from being imported, and it names Samsung, Google and Garmin. Apple isn't on the list this time. Gadgets & Wearables reported that the new filing is dated September 21 and carries docket number DN 3937.
The first complaint went after smartwatch fall detection. The commission opened that investigation in January 2026, after UnaliWear said watches from Apple, Google, Samsung and Garmin infringed two of its patents, numbers 10,051,410 and 10,687,193. That case is still pending before an administrative law judge.
The new one reads broader. The commission's receipt notice describes it as covering "wearable activity and health monitoring devices and systems containing same," and fall detection isn't in that wording. UnaliWear wants import restrictions and cease-and-desist orders on products it believes infringe its intellectual property.
Most of the detail is still missing. The Federal Register notice from September 24 doesn't name the patents, the patent claims or the products. The commission hasn't decided whether to open a formal investigation at all, so for now this is a filing and nothing more.
Apple dropped off the respondent list, and the public notices don't say why. The new allegations could cover technology Apple's watches don't use, or it could be a separate legal strategy. The notices don't give enough to choose between the two.
No watch faces a ban today. If the commission opens a case, it would run through evidence, claim interpretation and an initial determination before anyone reached a possible remedy. Garmin recently finished rolling out fall detection on the Venu 4, but nothing in the new notice ties the Venu 4, its 18.30 update or any other named Garmin device to DN 3937. Google and Samsung are in the same spot. Being named makes the filing relevant to Pixel Watch and Galaxy Watch owners, but it doesn't show that any particular watch uses what UnaliWear says it owns.
The commission's decision on whether to institute an investigation comes next. That's when the filing may name the patents, the products and the health features at the center of the dispute.